v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIENCY AND CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED SHARES - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Changes in redeemable convertible preferred stock    
Beginning balance $ 245,121 [1] $ 237,671
Beginning balance (in shares) 18,082,742 17,757,257
F1 preferred shares deemed dividend $ 1,694 $ 3,384
Issuance of F1 Adjustment warrants (in shares)   95,410
Exercise of F1 Ratchet warrants (in shares)   230,075
Exercise of F1 Ratchet warrants   $ 4,066
Rights Offering deemed dividends (note 12) 459  
Extinguishment of preferred shares (note 12) $ (148)  
Rights Offering share reorganization (note 12, 13) (in shares) 156,779,796  
Rights Offering share reorganization (note 12, 13) $ (129,695)  
Transfer of historical share issuance costs due to share reorganization (note 13) 4,024  
Share issuance costs $ (260)  
Settlement of convertible notes (note 9) (in shares) 14,955,023  
Settlement of convertible notes (note 9) $ 1,758  
Ending balance [1] $ 122,953 $ 245,121
Ending balance (in shares) 189,817,561 18,082,742
Changes in shareholders' deficiency    
Beginning balance $ (284,088) $ (220,726)
Beginning balance (in shares) 1,316,702  
Exercise of common share options $ 4 4
Share-based compensation (note 14) 1,345 1,253
F1 preferred shares deemed dividend (1,694) (3,384)
Exercise of F1 Ratchet warrants   (4,066)
Rights Offering deemed dividends (note 12) (459)  
Extinguishment of preferred shares (note 12) 148  
Rights Offering share reorganization (note 12, 13) 148,122  
Transfer of historical share issuance costs due to share reorganization (note 13) (4,024)  
Issuance of common share warrants (note 19) 1,067  
Net and comprehensive income (loss) for the year (34,225) (57,169)
Ending balance $ (173,804) $ (284,088)
Ending balance (in shares) 13,290,803 1,316,702
Class A common Shares    
Changes in shareholders' deficiency    
Number of shares converted to Common A shares 11,960,583  
Transfer of historical share issuance costs due to share reorganization (note 13) $ (4,024)  
Common Shares    
Changes in shareholders' deficiency    
Beginning balance $ 2,407  
Beginning balance (in shares) 1,316,702  
Ending balance $ 146,525 $ 2,407
Ending balance (in shares) 13,290,803 1,316,702
Common Shares | Class A common Shares    
Changes in shareholders' deficiency    
Beginning balance $ 2,407 $ 2,364
Beginning balance (in shares) 1,316,702 1,302,453
Exercise of common share options (in shares) 13,518 14,249
Exercise of common share options $ 8 $ 43
Rights Offering deemed dividends (note 12) 11  
Extinguishment of preferred shares (note 12) $ 11  
Number of shares converted to Common A shares 11,960,583  
Rights Offering share reorganization (note 12, 13) $ 148,122  
Transfer of historical share issuance costs due to share reorganization (note 13) (4,024)  
Ending balance $ 146,525 $ 2,407
Ending balance (in shares) 13,290,803 1,316,702
Additional paid-in capital    
Changes in shareholders' deficiency    
Beginning balance $ 15,920 $ 14,706
Exercise of common share options (4) (39)
Share-based compensation (note 14) 1,345 1,253
Issuance of common share warrants (note 19) 1,067  
Ending balance 18,327 15,920
Accumulated deficit    
Changes in shareholders' deficiency    
Beginning balance (298,566) (233,346)
F1 preferred shares deemed dividend (1,694) (3,384)
Exercise of F1 Ratchet warrants   (4,066)
Rights Offering deemed dividends (note 12) (459)  
Extinguishment of preferred shares (note 12) 137  
Net and comprehensive income (loss) for the year (31,370) (57,770)
Ending balance (331,952) (298,566)
Accumulated other comprehensive loss    
Changes in shareholders' deficiency    
Beginning balance (3,849) (4,450)
Net and comprehensive income (loss) for the year (2,855) 601
Ending balance $ (6,704) $ (3,849)
[1] Share amounts have been retrospectively adjusted to reflect the ten-for-one (10:1) reverse share split effective August 2025. See note 12 for details.